We Help ClientsGo Big.
Wilson Sonsini has an unrivaled legacy of representing start-ups through growth stages, and beyond.
Wilson Sonsini Goodrich & Rosati's legacy closely traces the birth and evolution of Silicon Valley.
For nearly six decades, Wilson Sonsini has represented the technology pioneers associated with virtually every milestone innovation.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
And as our clients have grown, so has our firm. Wilson Sonsini now represents many of the largest companies in the world—and thousands of the smallest ones, too.
Careers
We look for the best and brightest of tomorrow and develop careers from the ground up.
Leading Matters
News Articles
Wilson Sonsini Pro Bono Team Obtains Permanent Resident Status for Domestic Violence Survivor
A Wilson Sonsini pro bono team recently obtained permanent resident status for Rosa (not her real name), a Mexican woman who endured severe domestic violence when pregnant. Efforts were led by associate Jessica Yeh and Pro Bono Staff Coordinator Rodolfo Munoz, with guidance from litigation Of Counsel and Pro Bono Counsel Luke Liss. The latest victory follows the firm’s efforts in 2015, when a separate pro bono team helped Rosa secure U-visa nonimmigrant status from U.S. Citizenship and Immigration Services (USCIS).
Client Highlights
Wilson Sonsini Advises Women's, Family Digital Health Company Maven in $45 Million Series C
On February 19, 2020, Maven, a leading women's and family digital health company, announced it has closed $45 million in Series C funding, led by Icon Ventures, with participation from existing investors Sequoia, Oak HC/FT, Spring Mountain Capital, Female Founders Fund, Harmony Partners, and individual strategic investors Reese Witherspoon, Natalie Portman, Mindy Kaling, and Anne Wojcicki. The funding round is one of the largest investments for a female-led women's and family health firm. Wilson Sonsini Goodrich & Rosati represented Maven in the transaction.
Client Highlights
Wilson Sonsini and Taylor Wessing Advise Digital Surgery in Acquisition by Medtronic
On February 12, 2020, Digital Surgery, a privately-held pioneer in surgical artificial intelligence, data analytics, and digital education and training, announced its sale to Medtronic, a global leader in medical technology. Financial terms of the acquisition have not been disclosed. Wilson Sonsini served as U.S. legal counsel to Digital Surgery in collaboration with London-based law firm Taylor Wessing, which served as U.K. counsel in the transaction.
Client Highlights
Forescout Acquired for $1.9 Billion
On February 6, cybersecurity company Forescout Technologies announced that it had entered into a definitive agreement under which Advent International, a global private equity investor, will acquire all outstanding shares of Forescout common stock for $33.00 per share. Advent will be joined by Crosspoint Capital Partners, a private equity investment firm focused on the cybersecurity and privacy industries, as a co-investor and advisor. Wilson Sonsini Goodrich & Rosati advised Forescout in the transaction.
Client Highlights
Firm Represents InTouch Health in $600 Million Acquisition by Teladoc Health
On January 12, 2020, Teladoc Health, a global leader in virtual care, announced it has entered into a definitive agreement to acquire InTouch Health, a leading provider of enterprise telehealth solutions for hospitals and health systems, for $600 million. The acquisition positions Teladoc Health as the only virtual care provider covering the full range of acuity--from critical to chronic to everyday care--through a single solution across all sites of care worldwide. J.P. Morgan acted as sole financial advisor and Wilson Sonsini Goodrich & Rosati represented InTouch Health in the transaction.
Client Highlights
Pointy Is Acquired by Google
On January 15, Pointy, a retail tech start-up that helps brick-and-mortar stores sell goods online, announced that it had entered an agreement to be acquired by Google. Wilson Sonsini is representing Pointy in the transaction.
2019 Technology and Life Sciences IPO Report
The 2019 Technology and Life Sciences IPO Report includes analysis and data related to 87 U.S.-based technology and life sciences initial public offerings that priced between January 1 and December 31, 2019. The report includes IPO filing, pricing, and value statistics for both sectors; governance and board of director details; ownership and deal structure factors; defensive measure data points; and other matters.
